Article Details
Retrieved on: 2025-02-05 18:47:36
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Biogen and Eisai's regulatory update regarding Leqembi (lecanemab) for early Alzheimer's in the EU. It ties to the key concept of Alzheimer's and tags like Biogen, Eisai, and the broader pharmaceutical industry.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here